Mushroom Supplement Shows Promise in Slowing Senior Dogs' Cognitive Decline

A new study suggests that MycoDog's Clarity supplement could help senior dogs with cognitive decline. The 12-week trial involved 30 older dogs and showed promising results in memory, behaviour, and overall brain health. Researchers now plan to expand testing to a larger group of pets in real-world conditions.

The study focused on MycoDog's Clarity, a blend of medicinal mushrooms and adaptogens. Key ingredients included Lion's Mane, Reishi, Cordyceps, Ashwagandha, and Bacopa Monnieri. These were cultivated on natural substrates and processed using dual and spagyric extraction methods.

After 12 weeks, 81% of the dogs showed improved or stable cognitive scores. On average, their cognitive dysfunction scores dropped by 39%. Owners reported better orientation, sleep patterns, engagement, and house training. Many dogs also had calmer nights and higher-quality rest.

Biomarker tests revealed reduced inflammation and stronger neuroprotection. No adverse effects from the supplement were recorded during the trial. Dr. Joel Ehrenzweig, a veterinarian involved in the research, noted that Clarity could offer non-drug support for dogs in the early to moderate stages of cognitive decline.

The trial combined at-home assessments, wearable tracking devices, and clinical evaluations. MycoDog, the company behind Clarity, was founded by Angela Ardolino, a clinician with over 20 years of experience in holistic animal care. The next phase will open participation to more senior dogs through SeniorDogStudy.com.

The findings suggest Clarity may help slow cognitive decline in aging dogs without side effects. Further research will involve a larger group of pets in everyday settings. Owners interested in joining can sign up via the study's official website.